Lion Biotechnologies to Host Conference Call to Discuss Third Quarter 2016 Financial and Operating Results on Friday, November 4, ...
SAN CARLOS, CA--(Marketwired - October 28, 2016) - Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte technology (TIL), today announced that it will report its …